Affiliation:
1. Department of Physiology Johns Hopkins University School of Medicine Baltimore MD 21205 USA
2. Nanozyme Medical Center School of Basic Medical Sciences Zhengzhou University Zhengzhou 450001 China
3. Department of Veterinary Integrative Biosciences School of Veterinary Medicine and Biomedical Sciences Texas A&M University College Station Texas TX 77843 USA
4. Johns Hopkins Drug Discovery Johns Hopkins University School of Medicine Baltimore MD 21205 USA
5. Solomon H. Snyder Department of Neuroscience Department of Neurosurgery Johns Hopkins University School of Medicine Baltimore MD 21205 USA
Abstract
AbstractCytotoxic neuronal swelling and glutamate excitotoxicity are two hallmarks of ischemic stroke. However, the underlying molecular mechanisms are not well understood. Here, it is reported that SWELL1, the essential subunit of the volume‐regulated anion channel (VRAC), plays a dual role in ischemic injury by promoting neuronal swelling and glutamate excitotoxicity. SWELL1 expression is upregulated in neurons and astrocytes after experimental stroke in mice. The neuronal SWELL1 channel is activated by intracellular hypertonicity, leading to Cl− influx‐dependent cytotoxic neuronal swelling and subsequent cell death. Additionally, the SWELL1 channel in astrocytes mediates pathological glutamate release, indicated by increases in neuronal slow inward current frequency and tonic NMDAR current. Pharmacologically, targeting VRAC with a new inhibitor, an FDA‐approved drug Dicumarol, attenuated cytotoxic neuronal swelling and cell death, reduced astrocytic glutamate release, and provided significant neuroprotection in mice when administered either before or after ischemia. Therefore, these findings uncover the pleiotropic effects of the SWELL1 channel in neurons and astrocytes in the pathogenesis of ischemic stroke and provide proof of concept for therapeutically targeting it in this disease.
Funder
National Institute of General Medical Sciences
National Natural Science Foundation of China
National Institute of Neurological Disorders and Stroke
American Heart Association